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Integrin CD11b positively regulates TLR4-induced
signalling pathways in dendritic cells but not
in macrophages
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Philip R. Taylor4, Diane Scott1, Guido Franzoso2, H. Terence Cook1 & Marina Botto1
Tuned and distinct responses of macrophages and dendritic cells to Toll-like receptor 4
(TLR4) activation induced by lipopolysaccharide (LPS) underpin the balance between innate
and adaptive immunity. However, the molecule(s) that confer these cell-type-speciﬁc LPS-
induced effects remain poorly understood. Here we report that the integrin aM (CD11b)
positively regulates LPS-induced signalling pathways selectively in myeloid dendritic cells but
not in macrophages. In dendritic cells, which express lower levels of CD14 and TLR4 than
macrophages, CD11b promotes MyD88-dependent and MyD88-independent signalling
pathways. In particular, in dendritic cells CD11b facilitates LPS-induced TLR4 endocytosis and
is required for the subsequent signalling in the endosomes. Consistent with this, CD11b
deﬁciency dampens dendritic cell-mediated TLR4-triggered responses in vivo leading to
impaired T-cell activation. Thus, by modulating the trafﬁcking and signalling functions of TLR4
in a cell-type-speciﬁc manner CD11b ﬁne tunes the balance between adaptive and innate
immune responses initiated by LPS.
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L
ipopolysaccharide (LPS) is responsible for many of the
pathogenic effects of Gram-negative bacteria and can also
induce a protective adaptive immune response by acting
as adjuvant. While diverse cell types can respond to LPS, they may
mount qualitatively and quantitatively different responses1. The
molecules and mechanisms dictating the cell type speciﬁcity of the
LPS-induced effects remain poorly understood.
Dendritic cells (DCs) and macrophages (MFs) arise from
common myeloid precursors and share the ability to sample
the tissue environment but have distinct effector functions2. Both
types of cell sense microbes through pattern-recognition
receptors, which initiate downstream signalling events3.
However, as these cells mediate different immune functions,
their LPS response must be tuned to reﬂect their roles.
Toll-like receptors (TLRs) are the best-characterized pattern-
recognition receptors. TLR4 binds speciﬁcally to LPS and triggers
two distinct sequential signalling pathways3,4. The ﬁrst pathway
(MyD88-dependent) is initiated from the plasma membrane,
requires both MyD88 and TIRAP to activate NF-kB and initiate
cytokine production4. TLR4 is then internalized into the
endosome where a MyD88-independent pathway is triggered.
These second signalling events are controlled by the adaptor
molecules, TRAM (TRIF-related adaptor molecule) and TRIF
(TIR-domain-containing adapter-inducing interferon-b)5, which
activate Interferon (IFN) Regulatory Factor-3 (IRF3) leading
to the subsequent production of type I IFNs and CCL5
(RANTES)6,7. Although LPS responses depend on a membrane-
spanning complex formed by TLR4/MD-2, several molecules
have been shown to act as co-receptors and/or accessory
molecules and to regulate both positively and negatively LPS
sensing/signalling8. One such regulator is CD11b.
CD11b, which pairs with CD18 to form a heterodimeric type 1
transmembrane receptor (CD11b/CD18; b2aM,) known as Mac-1/
complement receptor 3 (CR3), has been suggested to contribute
to the LPS signalling cluster8. CD11b is highly expressed on
several cell types including MFs and DCs and can bind to
multiple ligands such as complement activation products (iC3b/
C3b) and LPS9. CR3 activation is mediated by conformational
changes often referred to as the ‘inside-out’ and ‘outside-in’
signalling pathways10.
CR3 plays a critical role in regulating inﬂammation and
antimicrobial immunity11. In vitro and in vivo observations have
also indicated a role for CD11b in TLR-triggered innate immune
responses; however, the nature of this cross-talk remains
controversial. On one hand, activation of CR3 through the
binding of iC3b or ﬁbrinogen delivers an ‘outside-in’ signal that
leads to the downregulation of LPS-induced inﬂammation11,12.
On the other hand, certain anti-CD11b antibodies or soluble
mediators can act synergistically with LPS13,14. Furthermore, a
recent study reported that CD11b could inhibit TLR signalling
even in the absence of exogenous ligands15, whereas many other
studies have shown that CD11b binds LPS and cooperates with
TLR4 to elicit an optimal LPS response16–19.
In the present study, we demonstrate that CD11b can serve
as a positive regulator of both TLR4-induced signalling path-
ways only on myeloid-derived DCs; however, it is dispensable in
fully differentiated MFs. The distinct role of CD11b in MFs and
DCs thereby provides an explanation for the apparently
conﬂicting results in the literature and sheds new light on the
regulation of the adaptive and innate immune responses triggered
by LPS.
Results
CD11b does not affect TLR4-induced cytokine response in
MUs. There is growing interest in understanding how CD11b
cross-regulates TLR4 signalling; however, the data in the litera-
ture are conﬂicting and thus the outcome of this cross-regulation
remains unresolved14,15,19. TLR responses have been often
investigated using thioglycolate-elicited peritoneal MFs15.
However, as the peritonitis induced by thioglycolate depends
on complement activation20 and complement-deﬁcient
animals, including CD11b-deﬁcient (Itgam / ) mice, mount
an abnormal cellular response20–22, we reasoned that resident
peritoneal MFs would provide a better controlled model.
Consistent with a recent report15, we found that thioglycolate-
elicited Itgam / peritoneal MFs produced more interleukin
(IL)-6 and tumour necrosis factor alpha (TNFa) in response to
LPS (Fig. 1a). However, these differences were detectable only
with thioglycolate-elicited peritoneal MFs, while resident
peritoneal MFs or bone marrow-derived MFs (BM-MFs)
from Itgam / and W/T animals secreted equivalent amounts
of cytokines (Fig. 1a). Further analysis of the thioglycolate-elicited
peritoneal MFs showed that Itgam / MFs expressed markedly
higher levels of major histocompatibility complex (MHC)II
than their W/T counterparts, indicating a different state of
activation. By contrast, MHCII expression on resident peritoneal
MFs and BM-MFs was similar between W/T and Itgam /
mice (Fig. 1b). Additional analysis of the peritoneal lavage
cells from thioglycolate-treated Itgam / mice revealed not only
that they express higher levels of MHCII, but also that the
percentage of F4/80hiCD115þ cells was signiﬁcantly higher
(Supplementary Fig. S1). This is consistent with previous
reports21,22 that CD11b deﬁciency affects the cellular
composition of the peritoneal lavage following thioglycolate
administration. Collectively, these data demonstrate that CD11b
is not involved in the regulation of the LPS-triggered
inﬂammatory response in steady-state MFs.
CD11b promotes MyD88-dependent TLR4 signalling in DCs.
We next compared the response of bone marrow-derived DCs
(BM-DCs) and BM-MFs over a range of LPS concentrations. We
found that Itgam / BM-DCs consistently secreted less IL-6
and TNFa, while Itgam / BM-MFs did not display any
impaired production (Fig. 2a). Consistent with these data, the
intensity of TLR4-induced MyD88-dependent phosphorylation of
p38, Erk1/2, JNK and IkBa was markedly reduced in LPS-sti-
mulated Itgam / BM-DCs but not in Itgam / BM-MFs
compared with the corresponding W/T cells (Fig. 2b and
Supplementary Fig. S8). Similar cytokine results were observed
with both adherent and ﬂoating bone marrow-derived myeloid
cells differentiated in vitro with granulocyte–macrophage colony
stimulating factor (GM-CSF) only (Supplementary Fig. S2b).
These cells are variably deﬁned in the literature as MFs or
DCs23–25, which may explain some of the conﬂicting results.
Notably, irrespective of the culture conditions applied, Itgam /
and W/T myeloid cells displayed similar maturation status before
LPS stimulation (Supplementary Fig. S2a). Moreover,
unstimulated Itgam / and W/T cells expressed similar levels
of TLR4 and CD14 (Supplementary Fig. S2a). The presence of
GM-CSF in the culture medium is critical for BM-DC
differentiation, and thus the different role exhibited by CD11b
on BM-DCs and BM-MFs could be the result of GM-CSF-
mediated cell programming rather than a lineage/differentiation-
speciﬁc effect, as shown for other molecules26. To explore this
possibility, we primed Itgam / and W/T BM-MFs with GM-
CSF or GM-CSF plus IL-4 prior to LPS stimulation
(Supplementary Fig. S3a). Under these conditions, the cells
acquired some DC-like phenotypic features, yet we did not
observe any difference in the cytokine production between W/T
and Itgam / cells indicating that the CD11b dependency in
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response to LPS is restricted to BM-DCs (Supplementary Fig.
S3b,c). As BM-MFs and BM-DCs exhibit different surface levels of
TLR4 and CD14 (Supplementary Fig. S2c) and CR3 has been
shown to bind LPS, we hypothesized that on cells bearing lower
levels of TLR4 and CD14, such as BM-DCs, CD11b is required
to promote the formation of the LPS recognition/signalling
complex18,19,27. We therefore examined CD11b surface
distribution after LPS stimulation using multispectral imaging
ﬂow cytometry. This analysis showed an increase in the percentage
of BM-DCs displaying clustered CD11b after LPS stimulation. In
contrast, the surface expression of CD11b remained evenly
distributed in LPS-treated BM-MFs (Fig. 3). In addition, using
an antibody that loses afﬁnity for TLR4 when the receptor interacts
with LPS (MTS510)28, we found that, upon LPS stimulation, TLR4
staining on Itgam / BM-DCs remained largely unchanged,
while it was signiﬁcantly decreased on W/T cells (Supplementary
Fig. S4a). Collectively, these data demonstrate that CD11b
facilitates LPS binding to TLR4 and acts as an additional
signalling partner in the LPS receptor signalosome complex on
BM-DCs, which express low levels of TLR4 and CD14, but not on
MFs. Thus CD11b contributes to the TLR4 signalling from the
plasma membrane in a cell-type-speciﬁc manner.
CD11b facilitates TLR4 endocytosis in BM-DCs. Recent work
has suggested that TLR4 can be delivered into endosomes, where
TRIF-dependent signalling can occur5, and that CD14 is essential
for this endocytic pathway triggered by LPS3. We next explored
whether CD11b can contribute to this process. We used the loss
of cell surface expression as readout for TLR4 endocytosis and the
production of RANTES as a surrogate for TRIF-mediated IRF3
activation3,6,7. As shown with the TLR4 signalling from the
plasma membrane, the lack of CD11b signiﬁcantly affected LPS-
induced TLR4 endocytosis only in BM-DCs, but not in BM-MFs
(Fig. 4a and Supplementary Fig. S4b). The delayed internalization
was speciﬁc as FcgR1 expression was largely unaffected by LPS
stimulation (Fig. 4a). Consistent with the hypothesis that CD11b
is part of the LPS receptor complex regulating TLR4 entry into
BM-DCs, upon LPS stimulation CD11b was internalized in W/T
BM-DCs, but not in BM-MFs (Fig. 4b). Likewise, LPS-induced
0
2,500
5,000
7,500
10,000
IL
-6
 (p
g m
l–1
)
6 h O/N
P = 0.0178
P = 0.0398
0
1,000
2,000
3,000
6 h O/N
TN
F-
α
 (p
g m
l–1
)
P = 0.0264
P =0.0476
0
2,500
5,000
7,500
6 h O/N
IL
-6
 (p
g m
l–1
)
0
1,000
2,000
6 h O/N
TN
F-
α
 (p
g m
l–1
)
0
100
200
300
400
6 h O/N
TN
F-
α
 (p
g m
l–1
)
0
250
500
750
6 h O/N
IL
-6
 (p
g m
l–1
)
a Thioglycolate-elicited
peritoneal MΦ Resident peritoneal MΦ Bone-marrow derived MΦ
W/T Itgam–/– Itgam–/– Itgam–/–
Itgam–/–
0
100
200
300
400
M
H
CI
I (M
FI)
P=0.0198
W/T
0
100
200
M
H
CI
I (M
FI)
W/T
0
5
10
15
M
H
CI
I (M
FI)
b
MHCII
W/T
W/T
Itgam –/–
60
40
20
0
Co
un
t
60
40
20
0
Co
un
t
Co
un
t
100 101 102 103 104
MHCII
100 101 102 103 104
MHCII
100 101 102 103 104
120
90
60
30
0
*
*
*
*
*
Figure 1 | LPS-induced proinﬂammatory cytokine production by MUs is not affected by CD11b deﬁciency. (a) Thioglycolate-elicited peritoneal MF,
resident peritoneal MF and bone-marrow derived MFs from W/Tor Itgam / mice were treated with LPS (10 ngml 1) for 6 or 24 h and the production
of IL-6 and TNF-a were measured using enzyme-linked immunosorbent assay (ELISA). (b) The surface expression of MHCII on different MFs was
examined using ﬂow cytometry prior to the LPS stimulation. Data are expressed as delta MFI (MFI¼ test-isotype control). Data are represented as mean
±s.e.m. from two independent experiments with three mice per group. *Po0.05 (t-test).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4039 ARTICLE
NATURE COMMUNICATIONS | 5:3039 | DOI: 10.1038/ncomms4039 |www.nature.com/naturecommunications 3
& 2014 Macmillan Publishers Limited. All rights reserved.
10 100 1,000 10 100 1,000
0
250
500
750
1,000
6 h O/N
LPS (ng ml–1):
IL
-6
 (p
g m
l–1
)
BM-MΦs BM-DCsa
W/T
Itgam –/–
10 100 1,000 10 100 1,000
0
5,000
10,000
15,000
20,000
6 h O/N
***
***
**
*
**
LPS (ng ml–1):
P=0.0096
P=0.0478
P=0.0007
P=0.0008
P =0.0087
P=0.079
NS
IL
-6
 (p
g m
l–1
)
10 100 1,000 10 100 1,000
0
2,500
5,000
7,500
10,000
6 h O/N
*
**
**
LPS (ng ml–1):
P=0.0199
P=0.0015
P=0.0016
TN
F-
α
 (p
g m
l–1
)
10 100 1,000 10 100 1,000
0
2,500
5,000
7,500
6 h O/N
LPS (ng ml–1):
TN
F-
α
 (p
g m
l–1
)
b
p-IκBα
GAPDH
p-Erk1/2
Total Erk1/2
p-p38
Total p38
15 min
CM LPS CM LPS
30 min 45 min
W/T Itgam –/–
CM LPS CM LPS
W/T Itgam –/–
CM LPS CM LPS
W/T Itgam –/–
15 min
CM LPS CM LPS
30 min 45 min
W/T Itgam –/–
CM LPS CM LPS
W/T Itgam –/–
CM LPS CM LPS
W/T Itgam –/–
BM-MΦs BM-DCs
p-JNK
Total JNK
15 30 45
0
1
2
3
4
P=0.042
*
P=0.0022
**
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-p
38
in
du
ct
io
n
15 30 45
0
1
2
3
4
P=0.047
*
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-E
rk
1/
2
in
du
ct
io
n
15 30 45
0
1
2
3
4
P=0.026
*
P=0.0141
*
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-J
NK
in
du
ct
io
n
13 30 45
0
1
2
3
4
P=0.04
*
P=0.005
**
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-Iκ
Bα
in
du
ct
io
n
15 30 45
0
2
4
6
8
10
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-p
38
in
du
ct
io
n
15 30 45
0
1
2
3
4
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-E
rk
1/
2
in
du
ct
io
n
15 30 45
0
2
4
6
8
10
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-J
NK
in
du
ct
io
n
15 30 45
0
2
4
6
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-Iκ
Bα
in
du
ct
io
n
kDa
43
43
44
42
44
42
54
46
54
46
40
37
kDa
43
43
44
42
44
42
54
46
54
46
40
37
Figure 2 | CD11b is required for MyD88-dependent TLR4 signalling and LPS-induced pro-inﬂammatory production in DCs. (a) BM-MFs and BM-DCs
from W/T or Itgam / mice were treated with the doses of smooth LPS as indicated, and the production of IL-6 and TNF-a was measured at
6 h and overnight (O/N). Data are mean±s.e.m. from three independent experiments, three mice per group. (b) W/Tor Itgam / BM-MFs and BM-DCs
were left untreated (CM) or treated with 1 mgml 1 of LPS for the time indicated. Phosphorylation of p38, Erk1/2, JNK and IkBa was examined using
western blot. Quantiﬁcation of band intensity showing the fold increase in phospho-protein levels relative to untreated cells and normalized to total protein
levels. Data are mean±s.e.m. from three independent experiments. *Po0.05, **Po0.01, ***Po0.005 (t-test).
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CD14 internalization was not affected by the lack of CD11b in
BM-MFs, but was inhibited in Itgam / BM-DCs, indicating
that the LPS-induced endocytic pathway in BM-DCs requires
both molecules (Supplementary Fig. S5a). This was further
investigated using confocal microscopy that showed co-staining
of CD11b and CD14 in BM-DCs only after LPS stimulation
(Fig. 4c). Both molecules appeared around LPS-induced
macropinosomes, which stained positive for the early
endosomal marker EEA1, conﬁrming the ﬂow cytometry data.
In contrast, the expression level of CD11c (integrin aX) remained
unchanged after LPS stimulation, demonstrating that this
molecule is not involved in TLR4 endocytosis (Supplementary
Fig. S5b). To demonstrate that CD11b was internalized by
endocytosis like TLR4, we used dynasore that blocks
endocytosis7. Dynasore treatment prevented the internalization
of both TLR4 and CD11b in BM-DCs (Fig. 4d), conﬁrming that
CD11b is part of the TLR4–endocytic cluster.
CD11b is required for LPS-induced RANTES secretion by DCs.
In agreement with the endocytic ﬁndings, Itgam / BM-DCs,
but not BM-MFs, were markedly defective in LPS-induced TRIF-
mediated RANTES production (Fig. 5a). Similar results were
observed with non-adherent GM-CSF-differentiated BM-derived
myeloid cells, which are widely used as BM-DCs (Supplementary
Fig. S2b). Consistent with the cytokine data, TRIF-mediated
TANK-binding kinase-I (TBK-1) and IRF3 phosphorylation were
markedly diminished in LPS-treated Itgam / BM-DCs com-
pared with W/T BM-DCs, but similar in BM-MFs (Fig. 5b and
Supplementary Fig. S9). By contrast, no obvious differences were
found in Akt or Syk phosphorylation in Itgam / BM-DCs
(Supplementary Fig. S5c and S11). Stimulation of BM-DCs with
LPS induces upregulation of MHC class II and co-stimulatory
molecules in a TRIF-dependent manner29. In keeping with the
signalling data, Itgam / BM-DCs displayed markedly
diminished induction of MHCII, CD80 and CD86 after LPS
stimulation (Fig. 5c) compared with the W/T BM-DCs. In
addition, this defect was speciﬁc for BM-DCs, as MHCII
expression was comparable in LPS-treated W/T and Itgam /
BM-MFs (Supplementary Fig. S5d). Collectively, these data
demonstrate that CD11b contributes to deliver TLR4 to
endosomes and is required to induce TRIF-dependent signalling
in BM-DCs.
Endosomal TLR4 endocytosis requires CD14 (ref. 3). If the
restricted role of CD11b in BM-DCs is determined at least in part
by the low expression of CD14, then increasing CD14 surface
expression should restore TLR4 endocytosis and TRIF-dependent
signalling. To test this, we increased the expression of CD14 by
stimulating BM-DCs with CpG DNA, a TLR9 ligand that does
not induce TRIF-IRF3 signalling events3,30. Consistent with
previous data3, CpG DNA treatment enhanced surface levels of
CD14 compared with immature BM-DCs. Interestingly, this
increase was even more pronounced in Itgam / BM-DCs
(Fig. 6a). The CpG-matured Itgam / BM-DCs, stimulated with
LPS, internalized TLR4 similarly to CpG-matured W/T BM-DCs
(Fig. 6a and Supplementary Fig. S10). However, the
normalization in TLR4 endocytosis did not rectify the TRIF-
dependent phosphorylation of IRF3 (Fig. 6b), nor did it restore
RANTES production in Itgam / BM-DCs to a level
comparable to W/T BM-DCs (Fig. 6c). As TLR9 stimulation is
known to involve MyD88/NF-kB signalling, IL-6 production was
not assessed. Although with this approach we cannot rule out
secondary effects of the CpG treatment, these data conﬁrm that
LPS-induced TLR4 endocytosis and signalling are independent
events3 and suggest that CD11b on BM-DCs regulates TRIF/
IRF3-dependent signalling from endosomes.
T-cell response elicited by LPS-primed DCs depends on
CD11b. TLR ligands such as LPS act as adjuvants for adaptive
immune responses29 and TLR-induced pro-inﬂammatory
cytokines, in particular IL-6 (ref. 31), regulate T-cell responses.
To test whether the adjuvant effect of LPS required CD11b on
DCs, we ﬁrst examined whether the impaired cytokine response
observed in LPS-treated Itgam / BM-DCs could inﬂuence
T-cell polarization in vitro. After 3-day stimulation with
conditioned medium (CM) from LPS-stimulated DCs in the
presence of transforming growth factor (TGF)-b, signiﬁcantly
more T regulatory cell and fewer Th17 cells were detected in the
cultures from Itgam / DCs compared with those from W/T
DCs (Supplementary Fig. S6a).
We then used the male-speciﬁc Y-chromosome-encoded minor
histocompatibility antigens (HY)32,33 model to assess the impact
in vivo. Intranasal (i.n.) administration of the MHC class II-
restricted HY peptide (HYAbDby) to female mice can induce
tolerance to HY-disparate skin grafts. However, this DC-
mediated tolerance induction can be converted to
immunization if LPS is co-administrated with the peptide32.
We therefore treated W/T and Itgam / female mice with HY
peptide alone or HY peptide plus LPS (HY peptide/LPS) and
isolated splenic DCs 24 h after the i.n. administration. In keeping
with ﬁndings using BM-DCs, we found less IL-6 and RANTES
producing splenic DCs in (HY peptide/LPS)-treated Itgam /
mice compared with (HY peptide/LPS)-treated controls and this
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Cells were ﬁxed, permeabilized and labelled with EEA1-alexa488 (green), CD11b-V450 (cyan) and CD14-alexa555 (red) antibodies, and analysed using
confocal microscopy. Images are representative of at least two independent experiments. Scale bars¼ 10mm. Left of the merged image plotted the
ﬂorescence spectra of each channel in the region of interest (ROI; yellow line). (d) W/T BM-DCs left untreated (circle) or treated with Dynasore (square)
or dimethylsulphoxide (cross) were stimulated with LPS (1 mgml 1). Surface levels of TLR4 and CD11b were measured at the times indicated. Displayed are
the MFIs of speciﬁc receptor staining at each time point (MFI at time 0 as 100%). Data are representative of three independent experiments
(mean±s.e.m., n¼ 3). *Po0.05, **Po0.01, ***Po0.005 (t-test).
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difference was not observed in the groups receiving HY peptide
alone (Fig. 7a). We then assessed the function of splenic DCs by
incubating them with naive CD4þ T cells isolated from HY-TCR
transgenic mice (Marilyn T cells)34. As previously published33,
DCs isolated from peptide-treated W/T mice induced only a very
weak proliferative response of the Marilyn T cells, while the i.n.
inoculation of the peptide with LPS boosted the ability of DCs to
induce T-cell proliferation (Fig. 7b). Itgam / splenic DCs from
the (HY peptide/LPS)-treated group, however, were severely
impaired in their ability to elicit proliferation of antigen-speciﬁc
T cells (Fig. 7b and Supplementary Fig. S6b). In addition, the
percentage of IL-6þ DCs was reduced in the cocultures with
in vivo (HY peptide/LPS)-primed Itgam / DCs compared with
the W/T counterparts (Fig. 7c). By contrast, no differences were
detected between W/T and Itgam / DCs that had been primed
with the peptide only (Fig. 7c).
Total IRF-3
Total TBK1
p-IRF-3
p-TBK1
W/T
30 min
CM LPS CM LPS
Itgam–/– W/T
CM LPS CM LPS
Itgam–/– W/T
CM LPS CM LPS
Itgam–/–
45 min 90 min
W/T
30 min
CM LPS CM LPS
Itgam–/– W/T
CM LPS CM LPS
Itgam–/– W/T
CM LPS CM LPS
Itgam–/–
45 min 90 min
84
84
kDa
84
84
kDa
55
55
55
55
b BM-MΦs BM-DCs
10 100 1,000
0
1
2
3
LPS
(ng ml–1):
10 100 1,000LPS
(ng ml–1):
R
AN
TE
S 
(ng
 m
l–1
)
0
10
20
R
AN
TE
S 
(ng
 m
l–1
)
0
1
2
3
P<0.0001
R
AN
TE
S 
(ng
 m
l–1
)
P<0.0001
0
10
20
30
40
*
*
R
AN
TE
S 
(ng
 m
l–1
)
P=0.0011
P=0.0438
P=0.0163
BM-MΦs BM-DCsa
6 h O/N
10 100 1,000LPS
(ng ml–1):
10 100 1,000LPS
(ng ml–1):6 h O/N
W/T
Itgam–/–
30 45 90
0
1
2
3
P=0.0212
*
P=0.0113
*
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-IR
F3
in
du
ct
io
n
30 45 90
0
1
2
3
4
5
P=0.0304
*
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-T
BK
1
in
du
ct
io
n
30 45 90
0
2
4
6
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-T
BK
1
in
du
ct
io
n
30 45 90
0
1
2
3
Time (min)
Fo
ld
 o
f p
ho
sp
ho
-IR
F3
in
du
ct
io
n
W/T
Itgam–/–
c
0
50
100
150 CM
LPS
MHC class II CD80 CD86
P=0.0021
M
FI
W/T Itgam–/– W/T Itgam–/– W/T Itgam–/–
P=0.0013
P=0.0001
***
***
***
**
**
***
Figure 5 | CD11b is required for TRIF-dependent TLR4 signalling in DCs. (a) W/Tor Itgam / BM-MFs and BM-DCs were treated with the indicated
doses of LPS and the amounts of RANTES secreted were measured using ELISA at 6 h and O/N. Data are mean±s.e.m. from three independent
experiments with three mice per group. (b) W/T or Itgam / BM-MFs and BM-DCs were left untreated (CM) or treated with LPS (1 mgml 1) for the
time indicated. The presence of phosphorylated (p-)TBK-1 and IRF3 was assessed using western blot. Quantiﬁcation of band intensity showing the fold
increase in phospho-protein levels relative to untreated cells and normalized to total protein levels. Data are mean±s.e.m. from three independent
experiments. (c) W/T or Itgam / BM-DCs were left untreated (CM) or treated with 1 mgml 1 of LPS for 24 h. DC maturation markers (MHC class II,
CD80 and CD86) were assessed using ﬂow cytometry. Data are expressed as delta MFI (MFI¼ test-isotype control). Data are representative of three
independent experiments (mean±s.e.m., n¼ 3) *Po0.05, **Po0.01, ***Po0.005 (t-test).
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To test the impact of the impaired TLR4 signalling in Itgam /
BM-DCs in vivo, we investigated whether the absence of CD11b
inﬂuenced the rejection pattern of syngeneic male skin graft
on female recipients receiving the HY peptide plus LPS.
First, we demonstrated that male skin grafted on untreated
Itgam / females was not rejected faster than on W/T females
(Fig. 7d) and that i.n. administration of HY peptide prolonged
equally the survival of syngeneic male skin grafts (Fig. 7d).
We then assessed the male graft survival after i.n. administration
of HY peptide/LPS. As expected, the rejection of the male skin
graft in HY peptide/LPS-pretreated W/T female mice followed
a faster time course (mean survival time (MST): 15 days) than
that of male skin grafts in untreated W/T females (MST: 34 days).
More importantly, HY peptide/LPS-pretreated W/T female
mice rejected the male skin grafts signiﬁcantly faster than the
Itgam / female mice with a MST of 15 and 27 days, respectively
(Fig. 7e). In addition, after re-exposure to male antigen, a reduced
expansion of UtyþCD8þ T cells and CD4þCD25þFoxp3
T cells was detected in HY peptide/LPS-pretreated Itgam / mice
compared with their W/T counterparts, suggesting poor T-cell
priming (Supplementary Fig. S6c). Taken together, these data
conﬁrmed in vivo the key modulating function of CD11b on LPS-
primed DCs.
Discussion
The recognition of microbial products by TLRs can trigger
innate immune responses and prime adaptive immunity. Key to a
ﬁne-tuned response is the existence of distinct responses
particularly in MFs and DCs1. Therefore, there is a lot of
interest in understanding how TLR activation is regulated in a
cell-type-speciﬁc manner. Our discovery that CD11b controls
LPS-induced signalling pathways in DCs but not in MFs
reconciles some of the conﬂicting reports in the literature and
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provides the molecular basis for distinct cellular responses to
microbial products.
CD11b is usually viewed as a MF-speciﬁc marker but it is
highly expressed on myeloid DCs. Here we demonstrate that
CD11b is a key mediator of the adjuvant effect of LPS in DCs, but
not in MFs. In the absence of CD11b, DCs showed defective LPS
binding to TLR4, impaired TLR4 signalling and poor induction of
T-cell responses. LPS stimulation induces CD11b clustering only
in DCs that express lower levels of TLR4 and CD14 compared
with MFs and thus require additional accessory molecules to act
as co-receptors for the full TLR4 signalling transduction16,18,35,36.
Our study demonstrates that CD11b promotes LPS binding to
TLR4 and is involved in both TLR4 signalling pathways and that
the CD11b dependency is not the result of a GM-CSF-mediated
cell-programming effect. In this context, it is of note that
CD11b-deﬁcient GM-CSF bone marrow-derived adherent cells
(Supplementary Fig. S2), which have a MF and DC overlapping
gene expression proﬁle23, secreted less IL-6 (MyD88-dependent)
but similar amounts of RANTES (TRIF-dependent) compared
with the W/T cells. The responses displayed by these cells are
consistent with the ﬁndings reported by Kagan et al.4 They
demonstrated that CD11b promoted TIRAP enrichment at the
plasma membrane and had a positive regulatory effect restricted
to the MyD88-dependent pathway4. On the basis of our
observations, we would argue that these CD11b-mediated
effects are likely to be restricted to a subtype of in vitro
differentiated myeloid cells or a stage of the MF/DC lineage
differentiation process.
Another novel ﬁnding of our study is the involvement of
CD11b in the DC endosomal TRIF-dependent pathway. This
pathway requires two steps: the initial TLR4 endocytosis and the
subsequent TRIF-mediated signalling in the endosomes7. CD11b
contributed to both stages. While CD14 has been shown to be
essential for the delivery of TLR4 to the endosomal signalling
machinery in DCs and MFs3, we found that the lack of CD11b
delayed TLR4 internalization only in DCs. Consistent with this
accessory role of CD11b, LPS-induced Syk3 and Akt37 activations
were not affected. Notably, while enhancing CD14 surface
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expression with CpG DNA treatment could compensate the
defect in TLR4 internalization, it was unable to compensate
defects in the TRIF/IRF3 signalling pathway. These data suggest
two separate roles of CD11b in DCs: one in promoting TLR4
endocytosis and one in TRIF-mediated signalling, the latter
appears to require CD11b irrespectively of the trafﬁcking events.
Our data also highlight the importance of CD11b in DC-
mediated TLR4 signalling in vivo, a ﬁnding that challenges the
traditional view of this molecule as a primary ‘phagocytic
receptor’. The impaired T-cell response induced by Itgam /
DCs upon LPS stimulation is consistent with the poor priming
and milder experimental allergic encephalomyelitis developed by
Itgam / mice when immunized with myelin oligodendrocyte
glycoprotein peptide plus complete Freund’s adjuvant that
activates TLR4 (ref. 38). The adjuvant effect of CD11b on LPS-
primed DCs provides a protective mechanism by which mature
DCs retain the ability to sense and respond to microbial
encounters by inducing T-cell differentiation.
The demonstration that CD11b inﬂuences the trafﬁcking and
signalling functions of TLR4 in BM-DCs but not in MFs may
also explain some of the discrepancies in the literature. A cell-
type-speciﬁc role can reconcile the observation that CD11b-
deﬁcient cells have an impaired IL-6 production in response to
LPS4 with the ﬁnding that a tail-less version of CD11b is unable
to promote phagocytosis but is still capable of eliciting a NF-kB-
mediated response to LPS16. Similarly, the explanation for the
conﬂicting ﬁndings that have been attributed to CD11b in various
disease models15,38–40 may lie in the predominant role played by
the different innate or adaptive immune cells in these
experimental conditions. Furthermore, a recent study suggested
that CD11b, in the absence of an exogenous ligand, can serve as
negative regulator of TLR-triggered inﬂammatory responses15. As
it appears that most of the observations in this study were
obtained using thioglycolate-elicited peritoneal MFs, we would
argue that the reported hyper-responsiveness of Itgam /
MFs to TLR stimulation15 is restricted to thioglycolate-elicited
peritoneal MFs. These MFs from Itgam / mice display an
abnormal state of activation prior to TLR4 stimulation that is
consistent with previous observations21,22, and the knowledge
that thioglycolate-induced peritonitis requires complement
activation20. Our data, however, do not exclude the possibility
that ligation of CD11b to ﬁbrinogen or iC3b can modulate TLR4
signalling in MFs. Wang et al.12 reported indirect inhibitor
effects mediated by activated CR3 when ligated with ﬁbrinogen
and we have obtained similar results using iC3b-coated particles
(Supplementary Fig. S7). Interestingly, we found that this
negative effect on TLR-triggered inﬂammatory responses is
restricted to MFs (Supplementary Fig. S7), suggesting a
dynamic cross-talk between TLRs and integrins whose outcome
is, at least in part, dependent on cell lineage/differentiation.
Collectively, our data and previous reports support the hypothesis
of a ‘signal-switch’ model41 whereby at sites of an acute
inﬂammation a strong CR3-mediated inhibitory signalling effect
on MFs may contribute to dampen the potential toxicity of the
cytokines generated by TLR stimulation, while during chronic
inﬂammation or in steady-state conditions, tonic CD11b
signalling triggered by low-avidity receptor ligation has no
detectable effects on TLR responses by MFs. These dual roles
of CD11b on MFs according to the surrounding would limit the
tissue damage during an acute infection without compromising
tissue homoeostasis.
In summary, our work demonstrates that CD11b facilitates
LPS binding to TLR4 and controls trafﬁcking and signalling
functions of TLR4 in a cell-type-speciﬁc manner by acting as an
important molecule in the cross-talk between adaptive and innate
immune responses. From an evolutionary perspective, these
differential effects of CD11b in MFs and DCs ensure a
coordinated and ﬁne-tuned cellular response appropriate for the
environmental trigger.
Methods
Mice. C57BL/6 mice were purchased from Charles River UK. C57BL/6-CD11b /
mice (Itgam–/–)21 were from Jackson Laboratory (Bar Harbor). Rag2 /
Marilyn mice (TCR transgenic for the HYAbDby peptide NAGFNSNRANSSRSS)
were a kind gift from Dr O Lantz34. Two to three months old female mice were
used. All animals were handled in accordance with the institutional guidelines and
procedures approved by the UK Home Ofﬁce in accordance with the Animals
(Scientiﬁc Procedures) Act 1986.
Cell culture. Thioglycolate-elicited MFs were isolated on day 4 from the peritoneum
of mice injected intraperitoneally with 0.5ml of 3% thioglycolate. Resident peritoneal
MFs were recovered from naive mice. BM-MFs and BM-DCs were generated by
culturing bone marrow cells with 20ngml 1 rM-CSF (PeproTech) for 7 days and
with 16.67 ngml 1 rGM-CSF (PeproTech) plus rIL-4 (5 ngml 1, PeproTech) for 6
days, respectively. Cells were stimulated with TLR4-grade LPS from Escherichia Coli
O111:B4 (Alexis Biochemicals). To enhance surface CD14 expression, BM-DCs were
stimulated with 0.5mM GpG (ODN 1826, Alexis Biochemicals) for 18 h. Splenic DCs
were isolated by CD11c MACs beads (Miltenyi Biotec) and Marilyn cells were pur-
iﬁed with CD4þ T cells isolation kit II (Miltenyi Biotec).
Flow cytometry. BM-MFs and BM-DCs were stained with the following anti-
bodies for phenotypic analysis: Fluorochrome-conjugated monoclonal antibodies
against CD11b (M1/70; dilution 1:200), CD11c (N418; dilution 1:100), CD115
(AFS98; dilution 1:100), CD80 (16-10A1; dilution 1:100), CD86 (GL1; dilution
1:100), F4/80(BM8; dilution 1:50) and MHC class II (AF6-120.1; dilution 1:100)
were from BD Biosciences Pharmingen. Monoclonal antibodies against TLR4
(Sa15-21 and MTS510) were from BioLegend. The Sa15-21 antibody was labelled
with biotin (Sigma). Both anti-TLR4 antibodies were added at a dilution of 1:50.
PerCp-Cy5.5-conjugated (dilution 1:50) and biotin-conjugated (dilution 1:100)
monoclonal antibodies against CD14 (Sa2-8) were from eBioscience. Data were
acquired using a FACSCalibur (Becton-Dickinson) and expressed as delta the mean
ﬂuorescent intensity (MFI of the sampleMFI of the isotype control).
ImageStream data acquisition and analysis. Cells were stimulated with
1 mgml 1 of LPS in polypropylene tube for different time points. After being ﬁxed
with 1% paraformaldehyde the cells were stained with PE-conjugated anti-mouse
CD11b (dilution 1:100). Images of 10,000 cells were acquired for each sample on
the ImageStream imaging cytometer System 100 (Amnis Corp). The data were
analysed using the ImageStream Data Exploration and Analysis Software (IDEAS,
Amnis). Receptor clustering was analysed as described42.
Immunoﬂuorescence microscopy. BM-DCs were grown on Bio-coat coverslips
(BD biosciences), ﬁxed in 4% paraformaldehyde, permeabilized with 0.1% saponin
and blocked with 5% goat serum. Samples were incubated with anti-CD11b-V450
(BD Biosciences, dilution 1:50), anti-CD14-biotin (ebioscience; dilution 1:50) and
rabbit anti-EEA1 (Cell Signaling Technology; dilution 1:100). Secondary antibodies
Alexa Fluor 555-conjugated Streptavidin and Alexa Fluor 488-conjugated goat-
anti-rabbit IgG were both from Molecular Probes and were added at a dilution of
1:100. Samples were then analysed with a Leica SP5 confocal microscope. Colo-
calization spectra of each channel in the region of interest were analysed using the
Lecia LAS AF software.
Immunoblotting. After LPS stimulation, cells were lysed with RIPA buffer (Sigma)
in the presence of protease inhibitor cocktail (Sigma) and phosphatase inhibitor
cocktail 2 (Sigma). Proteins were fractioned using 10 or 12% SDS–PAGE and
analysed using immunoblotting with the following antibodies: antibody speciﬁc for
p38 MAPK phosphorylated at Thr180/Tyr182 (3D7), Akt phosphorylated at
Ser473, Erk1/2 phosphorylated at Thr202/Tyr204 (197G2), IRF3 phosphorylated at
Ser396 (4D4G), IkBa phosphorylated at Ser32/36 (5A5), JNK phosphorylated at
Thr183/185 (81E11), Syk phosphorylated at Tyr525/526 (C87C1), TBK-1 phos-
phorylated at Ser172 (D52C2), p38 MAPK, Akt, Erk1/2 (137F5), IRF3(D83B9),
JNK, Syk, TBK-1 (D1B4) and GAPDH (14C10). All antibodies were from Cell
Signaling Technology and were used at a dilution of 1:1,000. Densitometry analysis
on the bands was performed using the NIH Image J software and normalizing the
data to total protein levels.
T-cell polarization assay. BM-DCs were stimulated with 1 mgml 1 LPS, and CM
was collected after 18 h. CD4þ T cells were puriﬁed from naive W/T mice and
activated with plate-bound anti-CD3 (2 mgml 1; Biolegend) and soluble anti-
CD28 (5mgml 1; eBioscience) in the presence of recombinant TGF-b1
(5 ngml 1, PeproTech). CM from W/T or Itgam / DCs was added to the T-cell
culture at a ratio of 1:1. On day 3, the cells were restimulated with 10 ngml 1 of
PMA (Sigma) and 250 ngml 1 of Ionomycin (Calbiochem) in the presence of
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GolgiStop (BD Pharmingen) for 5 h. Cells were then intracellularly stained
with PE-conjugated anti-IL-17 (TC11-18H10; dilution 1:100) and FITC-labelled
anti-IFN-g (XMG1.2; dilution 1:100) (BD Pharmingen). For the detection of
T regulatory cells, cells were intracellularly stained with antigen-presenting cell-
conjugated Foxp3 (FJK-16s; dilution 1:100) (eBioscience) before the PMA/Iono-
mycin re-stimulation.
Antigen presentation assay and skin graft. Two doses of 100mg HYAbDby
peptide with and without 3 mg LPS were administered intranasally to mice. Splenic
DCs were isolated 1 day after. Marilyn cells were added to DCs at 1:1 or 2:1
ratio. T-cell proliferation was assessed by thymidine incorporation after 48 h. To
assess IL-6-producing cells in the coculture, cells were restimulated with
10 ngml 1 of PMA and 250 ngml 1 of Ionomycin in the presence of GolgiStop
for 5 h. Phosphate-buffered saline (20ml) containing 100 mg HYAbDby peptide with
or without 3 mg LPS were administered intranasally on three consecutive days to
W/T and Itgam / female mice. Ten days later, the mice were grafted with
syngeneic male and female skin on the lateral thorax32.
Detection of HY-speciﬁc T cells in grafted mice. One hundred days after skin
grafting, mice were boosted with 5 106 male splenocytes intraperitoneally. Seven
days later, spleen cells (2 106) were cultured with irradiated male splenocytes
(2 106) and 10 IUml 1 recombinant mouse IL-2 (PeproTech). Live cells
were harvested on day 6, cells were stained with CD8a (FITC-labelled anti-mouse
CD8a, 53–6.7; dilution 1:100) and HYDbUty PE tetramer (ProImmune; 3 ml) to
detect HY-speciﬁc CD8þ T cells. To determine the percentage of activated
CD4þ T cells, cells were stained with CD4 (FITC-labelled anti-mouse CD4, L3T4),
CD25 (PE-labelled anti-mouse CD25, PC61) and Foxp3 (APC-labelled anti-mouse
Foxp3, FJK-16s); antibodies were added at 1:100 dilution.
Statistical analysis. Comparisons between two groups were performed using
two-tailed unpaired Student’s t-test or Mann–Whitney test. Graft survival was
compared using the log-rank (Mantel–Cox) test. Statistical signiﬁcance is
deﬁned as Po0.05.
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